Interview with ​Dr. Anatoli Kamali, Africa Regional Director at the International AIDS Vaccine Initiative

You’re listening to episode 3 of “African Research Excellence – DSW in conversation” – where each week Eoghan Walsh and Agustin Martin of DSW interview outstanding African researchers and advocates in the field of global health research, to learn more about their work and their views on the needs and opportunities to advance GH R&I in Africa.

2020 is set to be a big year for EU-Africa relations, and for global health – even before the Covid-19 emergency. Organisations like IAVI are at the forefront of both leading-edge research, and work on the ground in South Africa, to advance the cause of research and innovation targeted at eradicating diseases of poverty and neglected tropical diseases – HIV & AIDS, tuberculosis, malaria and others.

So we’re delighted to have on as a guest on this week’s episode Dr. Anatoli Kamali, Africa Regional Director at the International AIDS Vaccine InitiativeIn a wide-ranging and fascinating, we talked with Dr. Kamali about about:

  • How medical advances have transformed HIV & AIDS from a fatal diseases to a chronic, manageable condition
  • How much more we know now about HIV and AIDS than we ever have before, and about what works – from the early years of ABCs through to advances in mother-child transmission and ARVs, and on to PrEP.
  • How these advances are now being applied to the fight against Covid-19
  • And how, even as advances have been made, the AIDS pandemic remains a serious global health challenge, one where new infections and deaths from the disease can only be stopped with a HIV vaccine.

Thanks to Dr. Kamali for his time and his insight. You can find out more about DSW and the podcast at our website, dsw.org, and if you haven’t already please subscribe on your favourite podcast player! This podcast was edited by Jonathan Rowe, and the artwork was designed by Alissa Thaler.

Until next time.

Subscribe to our Newsletter

Join the conversation and receive special reports, newsletters, and invitations to special events. Sign up today! 😄

GDPR

You have Successfully Subscribed!